FDA Commissioner Stephen Hahn told a US Senate panel Tuesday that children may be included in clinical trials to determine if an experimental COVID-19 vaccine is effective, reported Bloomberg.
There are 125 vaccine candidates in development, including one developed at the National Institute of Allergy and Infectious Diseases (NIAID) in the National institutes of Health (NIH) that went into clinical testing in March.
Testing in children would only happen in future larger studies that determine if the vaccine meets the FDA's approval standards, the news source said.
"That's under discussion between the FDA and NIH at this time because we do realize it's important for us to understand what this is in children," Hahn said during the Senate Health, Education, Labor, and Pensions Committee hearing.
The Phase I study is fully enrolled, and NIAID director Anthony Fauci said he expects to move into the Phase II/III trials by late spring and early summer, adding that "if we are successful, we hope to know that in the fall and early winter."
To read more NewsPoints articles, click here.